Drug Profile
PF 06273588
Alternative Names: PF-06273588Latest Information Update: 25 Feb 2014
Price :
$50
*
At a glance
- Originator Pfizer
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 25 Feb 2014 Discontinued - Phase-I for HIV infections (in volunteers) in United Kingdom (IV)
- 25 Feb 2014 Discontinued - Phase-I for HIV infections (in volunteers) in United Kingdom (PO)
- 01 Jul 2011 Phase-I clinical trials in HIV infections in United Kingdom (IV)